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Pleurodesis outcomeAbstract Background: Pleurodesis fails in 10–40% of patients with recurrent malignant pleural
effusions (MPEs) and dyspnea. An accurate deﬁnition of the different characteristics of the patient
would help to identify more precisely the population mostly beneﬁting from pleurodesis.
Aim: We aimed to assess the values of the initial pleural ﬂuid LDH, CRP and pH characteristics
on pleurodesis outcome for MPEs.
Methods: Between April 2013 and December 2014, 40 patients with MPE were subjected to pleu-
rodesis with doxycycline and were divided into two groups, successful pleurodesis (group I) and
failed pleurodesis (group II) according to their radiographic response at the end of the 4 weeks
follow-up period. Before pleurodesis, pleural tapping and the initial pleural ﬂuid biochemical
parameters (Total protein, glucose, PH, LDH and CRP levels) were measured.
Results: After 4 weeks follow up, the success rate of pleurodesis was 62.5%. In successful pleu-
rodesis, the initial total pleural ﬂuid proteins, pleural ﬂuid LDH and pleural ﬂuid CRP were signif-
icantly lower than unsuccessful pleurodesis, with P-values <0.05, <0.001, <0.05 respectively
while, pleural ﬂuid glucose was statistically very highly signiﬁcantly lower at the unsuccessful pleu-
rodesis group (P< 0.001). Both groups together revealed positive correlation between pleural ﬂuid
LDH at one side and (pleural ﬂuid CRP and proteins) at the other side (P-value < 0.01 and <0.05)
respectively, while, there was a negative correlation between pleural ﬂuid LDH and pleural ﬂuid
glucose (P-value < 0.01). The complications of tube thoracotomy and pleurodesis in both success-
ful and failed pleurodesis were higher in unsuccessful pleurodesis than in successful pleurodesis.
Conclusion: High CRP, high LDH and low PH in MPEs have a poorer outcome of pleurodesis.
So, it may be advantageous when selecting patients for pleurodesis to include in their routine tests,
the initial pleural ﬂuid CRP, LDH and PH levels.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest
Diseases and Tuberculosis. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).rculosis.
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Most of the malignant pleural effusions are the result of metas-
tases to the pleura from other sites. The primary tumors were,
in the decreasing order of frequency: lung (37%), breast
(17%), unknown site (10%), lymphoma (9%), gastrointestinal
(8%), ovary (7%) and mesothelioma (3%) [1]. Management of
malignant effusions depends on palliation of dyspnea and pre-
vention of the reaccumulation of pleural ﬂuid to provide the
highest possible quality of life, regardless of the need for other
treatment modalities [2].
Pleurodesis is deﬁned as the symphysis between the visceral
and parietal pleural surfaces, its function is to prevent accumu-
lation of either air or ﬂuid into the pleural space. Effusions of
malignant origin are the most common indication for pleu-
rodesis [3].
Unfortunately, pleurodesis fails in 10–40% of patients with
recurrence of pleural ﬂuid and dyspnea. Because pleurodesis is
associated with considerable cost and morbidity, the identiﬁca-
tion of patients who will experience an unsuccessful pleurode-
sis would be desirable [4].
The utility of various clinical and biochemical parameters in
predicting pleurodesis outcome is still controversial. A better
deﬁnition of the different characteristics of the patient would
help to identify more precisely the population mostly beneﬁting
from pleurodesis. These factors may allow clinicians to make
better treatment decisions in a patient with recurrent MPE [5].Aim of the study
We aimed to assess the values of the initial pleural ﬂuid LDH,
CRP and pH characteristics on pleurodesis outcome for malig-
nant pleural effusions (MPEs).Patients and methods
Study population
 Over the period from April 2013 to December 2014, a
prospective study was conducted in which 40 consecutive
patients with malignancy and recurrent symptomatic malig-
nant pleural effusion (MPE) were found eligible to partici-
pate. Patients were admitted at Chest and Cardiothoracic
Surgery Departments, Zagazig University Hospitals, Egypt.
 They were diagnosed ﬁnally by pleural ﬂuid cytology
and/or CT-guided biopsy or tissue biopsy (Abrams or tho-
racoscopic biopsy).
 Informed consent was obtained from all patients enrolled in
the study. This consent was approved by the Institutional
Review Board at Zagazig Faculty of medicine
 Inclusion criteria
 Massive or rapidly reaccumulating pleural effusion after
drainage, which requires frequent thoracentesis
(<3 days).
 Subjective improvement of dyspnea following
thoracentesis.
 Re-expansion of the lung after drainage.
 Life expectancy > 6 months, Karnofsky scale
scoreP 60.
 Pleural ﬂuid pH > 7.2. Exclusion criteria
 Atelectasis due to endobronchial obstruction.
 Pleural ﬂuid pH < 7.2.
 Prior intrapleural therapy in the previous two weeks.
 Signiﬁcant irradiation to the affected hemithorax.
 Patient receiving systemic corticosteroids or a non-
steroid anti-inﬂammatory drug including pure analgesic
medication during the study.The following data were collected from all the patients
(1) Thorough medical history.
(2) Full clinical examination of both general and local
(chest) examinations.
(3) Assessment of Karnofsky performance status (KPS).
(4) Routine investigations to evaluate the patient general
condition (complete blood count, erythrocyte sedimen-
tation rate, and liver and kidney function tests).
(5) Plain chest X-ray (CXR) (postero-anterior and lateral
views).
(6) Before pleurodesis, pleural tapping and the aspirated
ﬂuid were analyzed for the following biochemical
parameters (Total protein, glucose, lactate dehydroge-
nase (LDH) and CRP levels).
(7) A 2-ml pleural ﬂuid sample was collected in a hep-
arinized syringe and the pleural ﬂuid pH was measured
within 30 min after thoracentesis, before pleurodesis.
The blood pH/gas analyzer, Rapid lab 1265 (Bayer,
USA), was used for these measurements.
ProceduresTube thoracostomy insertion
 Conventional large-bore chest tubes (24–28 F; Pleurocan,
Braun, Germany) were inserted in all cases.
 Patients were premedicated with 0.6 ml atropine sulfate
given intramuscularly 30 min prior to the procedure.
 Proper position with the patient supine, skin disinfection
and anesthesia was inﬁltrated with 10 CC xylocaine 2% fol-
lowed by aspiration to conﬁrm the presence of the ﬂuid.
 An incision about 2 cm was done in the ﬁfth or sixth inter-
costal space in the midaxillary line. The incision was made
at the upper border of the rib below and parallel to the rib.
A large bore chest tube (24–28 F) was used to allow adequate
drainage. After appropriate positioning, ﬁxation of the tube
was done by the suture. The chest tube was connected to
underwater seal to allow slow drainage of the effusion.
 When the amount of effusion became less than 100 ml/24 h
and chest X-ray showed complete lung expansion and there
was no evidence of bronchopleural ﬁstula, pleurodesis was
carried out.
Pleurodesis [1,6] Premedication with 20 cc xylocaine 2% (Astra Zeneca,
London, UK) was installed intrapleurally 30 min before
chemical agent was injected.
Table 1 Characteristics of the study population with success-
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Age (mean ± S.D.)
(years)
53.7 ± 26.3 48.2 ± 30.1 0.09
Gender No (%)
Female 7 (28%) 6 (40%) 0.66
Male 18 (72%) 9 (60%) 0.66
Tumor type No (%)
 Bronchogenic 9 (36%) 6 (40%) 0.8
 Mesothelioma 6 (24%) 4 (26.7%) 0.85
 Metastasis 8 (32%) 4 (26.7%) 1.00
 Hematologic
malignancy
2 (8%) 1 (6.6%) 0.64
Karnofsky
performance scale
(KPS), mean ± S.D.
76.9 ± 10.9 68.7 ± 8.3 0.31
Duration of drainage
after pleurodesis
(days), mean ± S.D.
3.7 ± 1.2 4.1 ± 1.1 0.26
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100 mg capsules, costing 20 LE for the pack) diluted
in100 ml of normal saline 0.09% into the pleural space,
Clamp chest catheter for 2 h, all patients underwent rota-
tional maneuvers during the time that the chest tube was
clamped. After 2 h, the tube was opened.
 The chest tube was removed when the drainage fell below
150 ml/24 h, and a chest X-ray was obtained to conﬁrm
complete lung expansion. All complications from the pleu-
rodesis were recorded.
 Each patient had a pre-drainage baseline posteroanterior
(PA) radiograph. Post-pleurodesis PA radiographs were
obtained at the following time: (1) after removal of the chest
tube, (2) 3 days after removal (early response), and (3)
4 weeks (late response) following the procedure.
Assessment of the response was based on radiologic appearance [5]
(1) At the end of the 4 weeks follow-up period, the radio-
graphic response was classiﬁed as follows: (1) complete
response (CR; no re-accumulation of pleural ﬂuid after
post-pleurodesis radiography), (2) partial response
(PR; re-accumulation above the post-pleurodesis level,
but below the pre-pleurodesis level), and (3) no response
(NR; re-accumulation or above the pre-pleurodesis
level).
(2) Global response refers to the sum of the complete and
partial responses [7].
(3) The patients who died or who were lost to follow-up
within the ﬁrst month of chest tube removal were
excluded from the study.
Statistical methods
Data were statistically described in terms of mean ± standard
deviation (±S.D.), or frequencies (number of cases) and per-
centages when appropriate. Comparison of numerical vari-
ables between the study groups was done using Student’s t
test for independent samples in comparison with normally dis-
tributed data. For comparing categorical data, Chi square (v2)
test was performed. The correlation of two continuous vari-
ables was measured with Pearson’s correlation coefﬁcient (r).
For all the above-mentioned statistical tests, the threshold of
signiﬁcance is ﬁxed at the 5% level (P-value), a P-valueP 0.05
indicates non-signiﬁcant results, a P-value < 0.05 indicates sig-
niﬁcant results, a P-value < 0.01 indicates high signiﬁcant
results, and a P-value < 0.001 indicates very high signiﬁcant
results.
All statistical calculations were done using computer pro-
gram SPSS (Statistical Package for the Social Science; SPSS
Inc., Chicago, IL, USA) version 15 for Microsoft Windows.
Results
Of the 40 patients who completed the study, 25 (62.5%)
patients showed successful pleurodesis (group I), while 15
(37.5%) patients showed failed pleurodesis (group II). The
mean age of the patients included in our study was
53.7 ± 26.3 and 48.2 ± 30.1 years in groups I and IIrespectively.18 patients were males and 7 were females, in
group I, while 9 patients were males and 6 were females, in
group II. The malignant pleural effusions were either of pri-
mary pleural origins (malignant mesothelioma) in 10 patients
or of metastatic etiology in 30 patients, of which 15 cases were
due to bronchogenic carcinoma, 12 cases were due to metasta-
sis from [Breast (9 patients), colon (2 patients) and ovary (one
patient)] and lastly 3 lymphoma patients The mean KPS was
comparable in the 2 studied groups. In addition, there was
no statistically signiﬁcant difference in the mean duration of
pleural ﬂuid drainage after pleurodesis in both groups
(Table 1).
There was statistically signiﬁcant difference between the
studied groups regarding the initial pleural ﬂuid values of (pro-
teins, glucose, LDH, and CRP) (Table 2).
Table 3 revealed that in both studied groups together, there
were positive correlations between the initial pleural ﬂuid
LDH at one side and (initial pleural ﬂuid CRP and proteins)
at the other side with statistically signiﬁcant difference
(P-value < 0.01 and <0.05) respectively. While, there was
negative correlation between the initial pleural ﬂuid LDH
and pleural ﬂuid glucose with statistically signiﬁcant difference
(P-value < 0.01). Other parameters (mean ages, KPS, pleural
ﬂuid PH and the mean duration of pleural ﬂuid drainage after
pleurodesis) showed no statistically signiﬁcant difference
(P-value > 0.05) in correlation with pleural ﬂuid LDH.
Table 4 shows that in the successful pleurodesis group (group
I), only the initial pleural ﬂuid proteins is signiﬁcantly negative
correlated with pleural ﬂuid LDH (P-value < 0.05).
Table 5 shows that in the failed pleurodesis group
(group II), the pleural ﬂuid PH was very highly signiﬁcantly
negatively correlated with the initial pleural ﬂuid LDH
(P-value < 0.001), while the initial pleural ﬂuid CRP and
Table 2 Comparison of the initial pleural ﬂuid glucose level,










4.54 ± 0.68 5.16 ± 0.79 <0.05
Pleural ﬂuid glucose
(mg/dl)
106.8 ± 10.5 53.7 ± 8.3 <0.001
Pleural ﬂuid LDH
(IU/l)
867 ± 130 1814 ± 691 <0.001
Pleural ﬂuid CRP
(mg/l)
2.62 ± 0.57 4.73 ± 1.63 <0.05
Pleural ﬂuid PH 7.47 ± 0.46 7.26 ± 0.04 0.23
Table 3 Correlation between all parameters and the initial
pleural ﬂuid LDH by Pearson correlation coefﬁcient in both
successful and failed pleurodesis groups together.
Variables (mean ± S.D.) r value P value
Age (years) 0.07 >0.05
Karnofsky performance scale (KPS) 0.02 >0.05
Pleural ﬂuid CRP (mg/l) 0.67 <0.01
Pleural ﬂuid pH 0.22 >0.05
Pleural ﬂuid proteins 0.36 <0.05
Pleural ﬂuid glucose 0.61 <0.01
Duration of drainage 0.02 >0.05
Table 4 Correlation between all parameters and the initial
pleural ﬂuid LDH by Pearson correlation coefﬁcient in the
successful pleurodesis group only.
Variables r value P value
Age (±S.D.) (years) 0.29 >0.05
Karnofsky performance scale (KPS) 0.1 >0.05
Pleural ﬂuid CRP (mg/l) 0.1 >0.05
Pleural ﬂuid PH 0.01 >0.05
Pleural ﬂuid proteins 0.43 <0.05
Pleural ﬂuid glucose 0.25 >0.05
Duration of drainage 0.05 >0.05
Table 5 Correlation between all parameters and the initial
pleural ﬂuid LDH by Pearson correlation coefﬁcient in the
failed pleurodesis group only.
Variables r value P value
Age (±S.D.) (years) 0.1 >0.05
Karnofsky performance scale (KPS) 0.22 >0.05
Pleural ﬂuid CRP (mg/l) 0.38 <0.05
Pleural ﬂuid pH 0.70 <0.001
Pleural ﬂuid proteins 0.30 <0.05
Pleural ﬂuid glucose 0.25 >0.05
Duration of drainage 0.14 >0.05
Table 6 Complications of tube thoracotomy and pleurodesis









Chest pain, No (%) 4 (16%) 4 (26.7%) >0.05
Fever, No (%) 4 (16%) 3 (20%) >0.05
Superﬁcial chest wall
infection, No (%)
0 (0%) 1 (6.6%) >0.05
Table 7 Radiological response after 3 days of tube thoraco-














20 (80%) 5 (30%) <0.05
Partial response, N
(%)
5 (20%) 7 (50%) <0.05
No response, N
(%)
0 (0%) 3 (20%) <0.05
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pleural ﬂuid LDH (P-value < 0.05).
As regards the complications of the tube thoracotomy and
pleurodesis, Table 6 reveals that in group I, chest pain, fever
and superﬁcial chest wall infection were 16%, 16% and 0%
respectively, while in group II, chest pain, fever and superﬁcial
chest wall infection were 26.7%, 20% and 6.6% respectively,
but with no statistically signiﬁcant difference between both
groups as regards these complications.
Table 7 demonstrates the radiologic response after 3 days
of tube thoracotomy and pleurodesis in which the (complete,
partial and no) response in both successful and failed pleu-
rodesis groups were 80%, 20% and 0% and 30%, 50% and
20% respectively, with statistically signiﬁcant difference
between both groups P-value < 0.05).Table 8 demonstrates the radiologic response after 4 weeks
of tube thoracotomy and pleurodesis in which the (complete,
partial and no) response in both successful and failed pleu-
rodesis groups were 68%, 32% and 0% and 0%, 0% and
100% respectively, with statistically signiﬁcant difference
between both groups P-value (<0.05).
Discussion
We aimed to assess the values of the initial pleural ﬂuid LDH,
CRP and pH characteristics on pleurodesis outcome for malig-
nant pleural effusion (MPE).
Over the period from April 2013 to December 2014, a
prospective study was conducted that included 40 consecutive
patients with recurrent symptomatic malignant pleural effu-
sion (MPE) who were eligible to participate.
Patients were admitted at Chest and Cardiothoracic
Surgery Departments, Zagazig University Hospitals. They
were diagnosed ﬁnally by pleural ﬂuid cytology and/or CT-
Table 8 Radiological response after 4 weeks of tube thora-













17 (68%) 0 (0%) <0.05
Partial response, N
(%)
8 (32%) 0 (0%) <0.05
No response, N (%) 0 (0%) 15 (100%) <0.05
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biopsy). Pleurodesis was done by injection of 500 mg of doxy-
cycline diluted in100 ml of normal saline 0.09% into the pleu-
ral space.
In our study, after 4 weeks follow up, the success rate of
pleurodesis was 62.5% (Table 1). The current study results
on doxycycline pleurodesis agreed with a study done by
Costa et al. [8] who treated 41 malignant pleural effusion
patients with doxycycline pleurodesis. A successful pleurodesis
(complete or partial) was accomplished in 25 (61%). Our
results were less than the following studies: Mohamed and
Hassan [9] who reported that the oral forms of doxycycline
pleurodesis (using 1000 mg of doxycycline and mixed in
50 ml physiological saline) in 22 patients with malignant pleu-
ral effusions were successful in sixteen patients (72.7%) at
1 month. Also, Herrington [10], who evaluated doxycycline
(1 g) as a pleurodetic agent in the treatment of malignant
and nonmalignant pleural effusions and refractory pneumoth-
oraces, Out of 12 patients with malignant pleural effusion, 8
(67%), achieved a complete response, 2 had a partial response,
and 2 had no response. Our results were less than the previous
2 studies because they used a higher dose and concentration of
doxycycline and a smaller number of patients than our study.
Elnady and Sakr [11], performed pleurodesis in twenty-
seven patients with malignant pleural effusion. (thoracoscopic
doxycycline poudrage ‘‘TDP’’) where about 500–1000 mg of
doxycycline was taken and prepared as a powder from the oral
preparation (Vibramycin 100 mg/capsule), 74.1% had a suc-
cessful pleurodesis, 18.5% had partial response and 7.4%
had failed pleurodesis at 1 month. This study used thoraco-
scopic pleurodesis, not tube thoracotomy as our study so the
former study results were better than our results.
The following 2 studies showed also better results than our
study may be due to larger number of patients, different tech-
niques or different pathological types of MPE used in our
study, Heffner et al. [12] examined the outcome in 31 patients
receiving doxycycline through a chest tube for malignant pleu-
ral effusions or persistent bronchopleural ﬁstulae, Of the 27
patients with malignant pleural effusions, 21 patients had suc-
cessful pleurodesis (77.8%) at 1 month. Porcel et al. [13] con-
ducted a prospective study of 36 rapid pleurodesis
procedures in 34 patients with malignant pleural effusions.
Patients received 500 mg of intrapleural doxycycline, complete
success of pleurodesis was achieved in (55%), partial success in
(26%), and failure in (19%). Thus, the overall success rate of
pleurodesis was 81%.
We observed in successful pleurodesis, the initial total pleu-
ral ﬂuid proteins, pleural ﬂuid LDH and pleural ﬂuid CRP weresigniﬁcantly lower than unsuccessful pleurodesis with P-value
<0.05, <0.001, <0.05 respectively while, pleural ﬂuid glucose
was statistically very highly signiﬁcantly lower at the unsuccess-
ful pleurodesis group (P< 0.001). The initial pleural ﬂuid PH
was lower in the unsuccessful group, but statistically insigniﬁ-
cant (Table 2). These results can be explained as the unsuccess-
ful pleurodesis is due to extensive intrapleural tumor deposits
that prevent the apposition of visceral to parietal pleural sur-
faces [14]. This abnormal pleural membrane appears primarily
responsible for low glucose [15]. The high level of CRP is an
indication of the inﬂammatory response within the pleural cav-
ity induced by neoplastic progression [16]. Also, high pleural
ﬂuid LDH levels (reﬂecting localized, acute inﬂammation,
necrosis and cell death within the pleural cavity) are indicative
of a poor prognosis in MPE [17]. Alsayed et al. [18] indicate
that pleurodesis success is much more liable if pleural ﬂuid
pH is > 7.30 and pleural glucose levels are > 60 mg/dl.
Below these values, pleurodesis failure is common. Several
studies reported conforming results such as Rodriguez-
Panadero and Mejias [19] who attempted pleurodesis in 62
patients having MPEs evaluated after a month. They stated
that there was a close relationship found between low pleural
glucose and pH levels and the extension of lesions observed
during follow-up and Heffner et al. [4] reported that the clinical
features of pleural ﬂuid pH (P-value 0.0001), pleural ﬂuid glu-
cose (P-value 0.0002), and %LDH (P-value 0.0005) were asso-
ciated with the failure of pleurodesis. Lapidot et al. [20] stated
that pleural ﬂuid CRP levels may reliably predict pleurodesis
success and symptomatic failure among MPE patients. So, it
may be advantageous when selecting patients for pleurodesis
to incorporate in the routine tests, the pleural ﬂuid CRP levels.
We choose the pleural LDH for comparison with the initial
pleural ﬂuid glucose level, protein level, pH, and CRP in both
successful and unsuccessful pleurodesis groups because LDH
elevation is an indicator of pleural inﬂammation and cell dam-
age. A signiﬁcant elevation is observed in pleural ﬂuid LDH
levels and pleural ﬂuid/serum LDH ratios in cases with malig-
nant effusions. Its measurement is highly sensitive and rou-
tinely done for the diagnosis of pleural effusion and for
predicting MPE prognosis [21] (Tables 3–5).
In our study, both groups together revealed a positive cor-
relation between pleural ﬂuid LDH on one side and (pleural
ﬂuid CRP and proteins) on the other side with statistically sig-
niﬁcant difference (P-value < 0.01 and < 0.05) respectively.
While, there was negative correlation between pleural ﬂuid
LDH and pleural ﬂuid glucose with statistically signiﬁcant dif-
ference (P-value < 0.01). This result was agreed with Alsayed
et al. [18] who stated that there was a signiﬁcant negative cor-
relation between glucose levels and LDH value in pleural ﬂuid
i.e. as glucose levels increased, LDH values decreased. This
meant that the malignant inﬁltration process of the pleura
was less severe (less LDH) resulting in better glucose transfer
into the pleural cavity (more glucose in pleural ﬂuid). In our
study, there was a positive correlation between both pleural
ﬂuid CRP and LDH as both were sensitive markers of pleural
inﬂammation and their levels increased and directly related to
the neoplastic progression. Other parameters (mean ages,
KPS, pleural ﬂuid PH and the mean duration of pleural ﬂuid
drainage after pleurodesis) showed no statistically signiﬁcant
difference (P-value > 0.05) in correlation with pleural ﬂuid
LDH, this may be due to small number of patients in the pre-
sent study (Table 3).
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LDH in successful pleurodesis group revealed that only initial
total pleural ﬂuid proteins were signiﬁcantly negative corre-
lated with initial pleural ﬂuid LDH levels (P-value < 0.05).
While, there was positive correlation between pleural ﬂuid
CRP and pleural ﬂuid LDH, but statistically insigniﬁcant
(Table 4). More studies with larger number of patients will
be needed to achieve signiﬁcant results.
The correlation between all parameters and pleural ﬂuid
LDH in the unsuccessful pleurodesis group revealed that the
pleural ﬂuid PH was very highly signiﬁcant negative correlated
with the initial pleural ﬂuid LDH (P-value < 0.001), while the
initial pleural ﬂuid CRP and proteins were signiﬁcantly posi-
tive correlated with the initial pleural ﬂuid LDH (P-
value < 0.05) (Table 5). Our results agreed with Alsayed
et al. [18] who reported that there was also a signiﬁcant nega-
tive correlation between glucose, LDH and pH values in pleu-
ral ﬂuid i.e. as glucose levels decreased, LDH values increased.
This meant that the malignant inﬁltration process of the pleura
was more severe (more LDH) resulting in less glucose transfer
from blood into the pleural cavity (less glucose in pleural ﬂuid)
and slow transport of its metabolic products (CO2 and Lactic
acid) out of pleural space thus resulting in low pH values of
pleural ﬂuid. Also, Shoukry [22] showed similar results. He
reported that pleural ﬂuid levels of pH and LDH were the
most sensitive markers that discriminated those with failed
pleurodesis from those with successful pleurodesis, where the
cut-off points that discriminated success from failure were
pH < 7.33 and LDH> 1023 IU/l and with decreasing
pH < 7.33 and increasing LDH> 1023 IU/l, there were
increased probabilities of pleurodesis failure.
The complications of tube thoracotomy and pleurodesis
(Chest pain, fever and infection) in both successful and failed
pleurodesis were higher in unsuccessful pleurodesis than suc-
cessful pleurodesis, this reﬂects that the pleurodesis is safe
and successful one, but there was no statistically signiﬁcant dif-
ference between both groups as regards the previous complica-
tions. Mohamed and Hassan [9] reported that the pain
observed in 10 cases (45.5%) was due to chest tubing or the
tumor itself rather than doxycycline powder. Analgesics, pre-
scribed in general for 24 h, easily overcame this problem. A
fever greater than 38.5 C lasting for about 24 h was a recorded
complication in 2 cases (9.1%) but it was easily controlled with
paracetamol. Bakr et al. [6] and Herrington [10] found twenty-
two (81%) of 27 patients in their studies experienced adverse
effects with pleurodesis, with pain (81%) and fever (11%) being
the most prevalent. As pain is the most common complication
associated with doxycycline pleurodesis, narcotic analgesic
and/or conscious sedation is often recommended or the solu-
tion may be mixed with 10 ml of lignocaine to reduce pain.
Also, Elnady and Sakr [11], concluded that doxycycline is inex-
pensive, well tolerated, reasonably effective, comparatively
simple, safe, and capable of alleviating respiratory symptoms.
Table 7 shows the response after 3 days of tube thoraco-
tomy and pleurodesis in both successful and failed pleurodesis,
in which the (complete, partial and no) response in all 40
patients together was 62.5%, 30% and 7.5% respectively.
Bakr et al. [6] reported that The immediate follow up results
(24–72 h of pleurodesis) showed that in group II (pleurodesis
with doxycycline), 8 patients had CR (80%) while partial
response (PR) was recorded in 1 case (10%) and failure in 1
case (10%).Table 8 shows the response after 4 weeks of tube thoraco-
tomy and pleurodesis in both successful and failed pleurodesis,
in which the (complete, partial and no) response in all 40
patients together were (42.5%, 20% and 37.5%) respectively.
While, Bakr et al. [6] reported that after two and three months
follow up of the patients in group II (pleurodesis with doxycy-
cline), 8 patients had CR (80%), while failure was found in 2
cases (20%), the later results were better than our results which
may be due to smaller number of patients (10) included in the
later study, also they used more concentrated doxycycline for
pleurodesis (Seven milligram per kilogram of doxycycline
diluted in 50 ml of saline 0.9%).Conclusion
Success of pleurodesis is decided by observing whether or not
symptomatic ﬂuid occurs 4 weeks after sclerosing agent appli-
cation. When we predict the outcome of the pleurodesis proce-
dure, it might allow us to avoid performing this invasive
procedure with its side effects or might allow the re-
application of sclerosing agent within the ﬁrst two or three
days before the chest tube is withdrawn.
The initial pleural ﬂuid CRP, LDH and PH levels may reli-
ably predict pleurodesis success and symptomatic failure
among MPE patients. As, high CRP, high LDH and low PH
in MPEs have a poorer outcome of pleurodesis. So, it may
be advantageous when selecting patients for pleurodesis to
incorporate in their routine tests, the initial pleural ﬂuid
CRP, LDH and PH levels.Conﬂict of interest
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